For the quarter ending 2026-03-31, EKSO had $2,824K increase in cash & cash equivalents over the period. -$2,123K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Changes in provision for credit losses on accounts receivable | - | -42 | -13 | 5 |
| Net loss | -6,885 | -4,674 | -1,421 | -5,600 |
| Depreciation and amortization | 454 | 451 | 367 | 755 |
| Loss on impairment of intangible asset | 0 | 570 | 0 | 180 |
| Changes in provision for credit losses on accounts receivable | 323 | - | - | - |
| Loss (gain) on revaluation of warrant liabilities | -727 | 0 | 0 | 1 |
| Finance cost associated with warrant issuance | 145 | - | - | - |
| Loss on impairment of right-of-use asset | 89 | - | - | - |
| Stock-based compensation expense | 114 | 783 | 234 | 457 |
| Loss on modification of warrant | - | 0 | 0 | 0 |
| Common stock contribution to 401 plan | 0 | 72 | 64 | 15 |
| Unrealized loss (gain) on foreign currency transactions | -239 | -4 | 4 | 1,965 |
| Accounts receivable | -2,423 | 1,099 | 1,507 | -3,052 |
| Inventories | -168 | -112 | -494 | 881 |
| Prepaid expenses and other assets, current and noncurrent | 115 | -260 | 283 | 164 |
| Accounts payable | 679 | -232 | 216 | -121 |
| Accrued, lease and other liabilities, current and noncurrent | -188 | -348 | -38 | -716 |
| Deferred revenues | -296 | -188 | -170 | -425 |
| Net cash used in operating activities | -2,123 | -4,331 | -2,061 | -5,409 |
| Acquisition of property and equipment | 0 | 126 | 12 | 50 |
| Net cash used in investing activities | 0 | -126 | -12 | -50 |
| Principal payments under notes payable | 313 | 312 | 313 | 625 |
| Retirement of term loan-Term Loan | - | 0 | 2,000 | - |
| Proceeds from issuance of common stock, net | - | 3,232 | -48 | 914 |
| Proceeds from issuance of series b convertible preferred stock and january 2026 private placement warrants, net | 5,265 | - | - | - |
| Proceeds from exercise of warrants, net | 0 | 0 | 0 | 3,856 |
| Proceeds from issuance of convertible promissory note, net-Promissory Note | - | 1 | 1,924 | - |
| Net cash provided by financing activities | 4,952 | 2,921 | -437 | 4,145 |
| Effect of exchange rate changes on cash | -5 | -17 | -10 | 63 |
| Net increase in cash | 2,824 | -1,553 | -2,520 | -1,251 |
| Cash and restricted cash at beginning of period | 1,169 | 2,722 | 6,493 | - |
| Cash and restricted cash at end of period | 3,993 | 1,169 | 2,722 | - |
EKSO BIONICS HOLDINGS, INC. (EKSO)
EKSO BIONICS HOLDINGS, INC. (EKSO)